Carcinoma News and Research

RSS
Carcinoma is cancer that begins in the skin or in tissues that line or cover internal organs.
Immunotherapy for kidney cancer - Phase 3 update from Argos Therapeutics at ASCO

Immunotherapy for kidney cancer - Phase 3 update from Argos Therapeutics at ASCO

MD Anderson researchers find significant clinical variations among liver cancer patients

MD Anderson researchers find significant clinical variations among liver cancer patients

Simple blood test could help predict effectiveness of interferon-based therapy in HCV-infected patients

Simple blood test could help predict effectiveness of interferon-based therapy in HCV-infected patients

Researchers identify three genes involved in choroid plexus carcinoma

Researchers identify three genes involved in choroid plexus carcinoma

Overview of Blueprint Medicines' kinase drug discovery strategy published in JCI

Overview of Blueprint Medicines' kinase drug discovery strategy published in JCI

Can-Fite receives EMA clearance to begin CF102 Phase II trial for treatment of HCC patients in Europe

Can-Fite receives EMA clearance to begin CF102 Phase II trial for treatment of HCC patients in Europe

Chemotherapy benefit in nasopharyngeal carcinoma confirmed

Chemotherapy benefit in nasopharyngeal carcinoma confirmed

Cardiff scientists develop novel anti-cancer stem cell compound

Cardiff scientists develop novel anti-cancer stem cell compound

Exalenz Bioscience investigates clinical utility of BreathID test to diagnose NASH

Exalenz Bioscience investigates clinical utility of BreathID test to diagnose NASH

Will new hepatitis C treatments strain payers’ budgets? An interview with Dr Chhatwal

Will new hepatitis C treatments strain payers’ budgets? An interview with Dr Chhatwal

Occurrence of advanced liver fibrosis similar for patients with HCV infection

Occurrence of advanced liver fibrosis similar for patients with HCV infection

Therapeutic candidate BLU-554 has significant anti-tumor activity in HCC models

Therapeutic candidate BLU-554 has significant anti-tumor activity in HCC models

Study identifies BLU-554 as potential treatment option for HCC patients

Study identifies BLU-554 as potential treatment option for HCC patients

Exome sequencing helps identify link between environmental exposures and mutational patterns in HCC

Exome sequencing helps identify link between environmental exposures and mutational patterns in HCC

Long-term ETV or TDF therapy improves survival rate for Caucasian patients with CHB

Long-term ETV or TDF therapy improves survival rate for Caucasian patients with CHB

Honokiol extract holds promise as adjunct treatment for bladder and kidney cancers

Honokiol extract holds promise as adjunct treatment for bladder and kidney cancers

UNM Cancer Center enrolls first patient in phase 3 international clinical trial for kidney cancer vaccine

UNM Cancer Center enrolls first patient in phase 3 international clinical trial for kidney cancer vaccine

Can-Fite seeks EMA Orphan Drug Designation for CF102 in HCC

Can-Fite seeks EMA Orphan Drug Designation for CF102 in HCC

New method for measuring genetic variability may help identify patients with aggressive cancers

New method for measuring genetic variability may help identify patients with aggressive cancers

Scientists identify way to potentially predict progression in patients with early form of breast cancer

Scientists identify way to potentially predict progression in patients with early form of breast cancer

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.